Anthony L. Boral, Chief Medical Officer at Blueprint Medicines Corp (BPMC), sold 19,900 shares at $94.18 ($1.9M) on 2019-07-08, disclosed to the SEC on 2019-07-10.
Open-market sale of $1.9M BPMC by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $92.79 | 100 | $9K | 0.5% |
| 2 | $93.56 | 4,685 | $438K | 23.5% |
| 3 | $93.56 | 4,685 | $438K | 23.5% |
| 4 | $94.18 | 5,215 | $491K | 26.3% |
| 5 | $94.18 | 5,215 | $491K | 26.3% |
| Total | $93.88 avg | 19,900 |
| $1.9M |
| 100% |
| Filing → |
| BPMC | SELL | 2020-09-21 | $1.9M | — | Filing → |
| BPMC | SELL | 2020-03-11 | $28K | — | Filing → |
| BPMC | SELL | 2019-12-19 | $1.5M | — | Filing → |